Alpha 2.0
Login Register
» Authors » Gonzalo Nocea

Gonzalo Nocea

Explore the profile of Gonzalo Nocea including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 110
Followers 0
Related Specialties
General Medicine
Public Health
Pharmacology
Top 10 Co-Authors
Virginia Lozano
Ritesh N Kumar
Yang Xie
Cristina Carbonell
Panagiotis Mavros
Santiago Grau
Adolfo Diez
Maria Teresa Caloto
Amparo Valladares
Ma Teresa Caloto
Published In
Curr Med Res Opin
Health Qual Life Outcomes
Menopause
Infect Drug Resist
Clinicoecon Outcomes Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up
Canete J, Naranjo A, Calvo J, Ordas C, Aragon B, Nocea G, et al.
Reumatol Clin (Engl Ed) . 2019 Feb; 16(6):447-454. PMID: 30704919
Objectives: To describe the therapeutic management of Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS) in patients initiating treatment with biological agents. Materials And Methods: Observational, retrospective, longitudinal...
2.
Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain
Davis A, Brogan A, Goodwin B, Nocea G, Lozano V
HIV Clin Trials . 2017 Dec; 18(5-6):214-222. PMID: 29210626
Introduction: The AIDS Clinical Trial Group (ACTG) 5257 clinical trial showed that raltegravir (RAL) was superior to atazanavir/ritonavir (ATV/r) and darunavir/ritonavir (DRV/r), when used in combination with emtricitabine/tenofovir DF (FTC/TDF),...
3.
Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain
Nolla J, Rodriguez M, Martin-Mola E, Raya E, Ibero I, Nocea G, et al.
Patient Prefer Adherence . 2016 Jul; 10:1101-13. PMID: 27382258
Purpose: To define importance values assigned to attributes of biological agents (BAs) by Spanish patients with rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis) and rheumatologists. Patients And Methods:...
4.
Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
Appl Health Econ Health Policy . 2015 Mar; 13(4):369-79. PMID: 25761545
Background And Objective: The microbial susceptibility of many antibiotics has been affected by prescribing patterns and their extensive use. The purpose of this evaluation was to assess how these changes...
5.
Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
Clinicoecon Outcomes Res . 2014 Mar; 6:83-92. PMID: 24611019
Background: Clinical efficacy of antibiotics may be affected by changes in the susceptibility of microorganisms to antimicrobial agents. The purpose of this study is to assess how these changes could...
6.
Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada
Ambegaonkar B, Bash L, Chirovsky D, Jameson K, Grant S, Nocea G, et al.
Eur J Intern Med . 2013 Aug; 24(7):656-63. PMID: 23953848
Background: Although low-density lipoprotein cholesterol (LDL-C) is the primary lipid target for cardiovascular disease (CVD) risk reduction, high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) have also emerged as risk factors....
7.
Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
Fan T, Nocea G, Modi A, Stokes L, Sen S
Clin Interv Aging . 2013 Jul; 8:689-96. PMID: 23818767
Background: Osteoporotic fractures are important causes of morbidity, mortality, and increased health care costs. However, the risk of osteoporotic fractures can be decreased, with clinical studies supporting the use of...
8.
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Wissing H, Ballus J, Bingold T, Nocea G, Krobot K, Kaskel P, et al.
Infect Drug Resist . 2013 Feb; 6:15-25. PMID: 23386790
Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units...
9.
Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire
Dauden E, Herrera E, Puig L, Sanchez-Carazo J, Toribio J, Caloto M, et al.
Health Qual Life Outcomes . 2012 May; 10:56. PMID: 22624984
Background: Several questionnaires have been used to measure health related quality of life (HRQoL) in patients with psoriasis, few have been adapted for use in Spain; none of them was...
10.
[Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice]
Carbonell C, Diez A, Calaf J, Caloto M, Nocea G, Lara N
Reumatol Clin . 2011 Nov; 8(1):3-9. PMID: 22118802
Objective: To describe the percentage of prescription of pharmacologic supplements in patients starting antiresorptive treatment (ART) for osteoporosis by specialists. Design: Cross-sectional, naturalistic, multicenter study with retrospective data collection. Patients...